08:52 AM EST, 11/21/2024 (MT Newswires) -- Health care stocks rose in pre-bell hours Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.1% higher and the iShares Biotechnology ETF (IBB) up 0.3% recently.

Zymeworks ( ZYME ) and Jazz Pharmaceuticals ( JAZZ ) said they have received accelerated approval for Ziihera from the US Food and Drug Administration to treat adult patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer. Zymeworks ( ZYME ) shares were up over 8% and Jazz Pharmaceuticals ( JAZZ ) shares were almost 4% higher premarket.